Human monoclonal antibodies against interleukin 8 (il-8)
CA 2510087 C · Owner: Parren, Paul · Inventors: Petersen, Jorgen; Hudson, Debra; Baadsgaard, Ole D. M. Sc.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Isolated human monoclonal antibodies which bind to IL-8 (e.g. human IL-8) are disclosed. The human antibodies can be produced in a hybridoma transfectoma , or in a non-human transgenic animal e.g. a transgenic mouse, capable of , producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies non-human transgenic animals, hybridomas and transfectomas which produce the human antibodies and , therapeutic and diagnostic methods for using the human antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 16, 2003 and granted September 4, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 16, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 16, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.